Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Fabrazyme (agalsidase beta) on Lactation and Infants in Fabry Disease
2006-001910-33Phase 4Unknown
- Sponsor
- Sanofi
- Start
- May 2006
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of agalsidase beta in Fabry disease (FD), sponsored by Sanofi. Primary endpoint: Maternal primary endpoint. Status: unknown.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on 2006-001910-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001910-33.